Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan
· Delayed Price · Currency is TWD 117.00
+1.50 (1.30%)
Apr 24, 2025, 1:30 PM CST
Alar Pharmaceuticals Market Cap
Alar Pharmaceuticals has a market cap or net worth of 7.82 billion as of April 24, 2025. Its market cap has decreased by -62.38% in one year.
Market Cap
7.82B
Enterprise Value
5.39B
Revenue
5.82M
Ranking
n/a
PE Ratio
430.14
Stock Price
117.00
Market Cap Chart
Since October 5, 2020, Alar Pharmaceuticals's market cap has increased from 2.57B to 7.82B, an increase of 204.70%. That is a compound annual growth rate of 27.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 7.82B | -17.31% |
| Dec 31, 2024 | 9.45B | -20.85% |
| Dec 29, 2023 | 11.94B | 82.17% |
| Dec 30, 2022 | 6.56B | 151.37% |
| Dec 30, 2021 | 2.61B | -6.63% |
| Dec 31, 2020 | 2.79B | 8.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 160.86B |
| Caliway Biopharmaceuticals | 93.07B |
| Bora Pharmaceuticals Co., LTD. | 67.36B |
| Lotus Pharmaceutical | 54.79B |
| Polaris Group | 28.88B |
| Oneness Biotech | 28.11B |
| Pegavision | 25.35B |
| Lumosa Therapeutics | 24.91B |